Akebia Therapeutics
AKBA
#9600
Rank
NZ$0.19 B
Marketcap
NZ$0.71
Share price
-8.24%
Change (1 day)
-75.03%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2026 (TTM): -NZ$75.65 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2025 the company made an earning of -NZ$6.8 Million, an increase over its 2024 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$75.65 Million1013.88%
2025 -NZ$6.8 Million-94.64%
2024 -NZ$0.13 Billion33.68%
2023 -NZ$94.77 Million-45.12%
2022 -NZ$0.18 Billion-66.55%
2021 -NZ$0.52 Billion-26.24%
2020 -NZ$0.7 Billion33.94%
2019 -NZ$0.53 Billion66.52%
2018 -NZ$0.32 Billion123.53%
2017 -NZ$0.15 Billion-43.34%
2016 -NZ$0.25 Billion123.58%
2015 -NZ$0.12 Billion63.95%
2014 -NZ$67.59 Million181.24%
2013 -NZ$24.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.16 B-43,455.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$23.07 B-29,379.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$20.17 B-25,695.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 254.59%๐Ÿ‡บ๐Ÿ‡ธ USA